Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004

Cancer

Volumn 110, Issue 6, 2007, Pages 1255-1263

  Robbins, Anthony S ^a   Koppie, Theresa M ^b   Gomez, Scarlett L ^c,d   Parikh Patel, Arti ^a   Mills, Paul K ^a  

^a PUBLIC HEALTH INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NORTHERN CALIFORNIA CANCER CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asians; Prostate cancer; Survival; Whites

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RACE DIFFERENCE; RISK FACTOR;

AGED; ASIAN AMERICANS; CALIFORNIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 34548715340     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22872     Document Type: Article

References (37)

1. Stanford JL, Stephenson RA, Coyle LM, et al., editors. Prostate Cancer Trends 1973-1995, SEER Program, National Cancer Institute. NIH Pub. No. 99-4543. Bethesda, MD: National Cancer Institute; 1999.
2. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Arch Intern Med. 2002;162:1985-1993.
3. Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW, O'Malley CD. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer. 2002;94:1175-1182.
4. Oakley-Girvan I, Kolonel LN, Gallagher RP, Wu AH, Felberg A, Whittemore AS. Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients. Am J Public Health. 2003;93:1753-1759.
5. Young JL, Gloeckler Ries L, Pollack ES. Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst. 1984;73:341-352.
6. Gomez SL, Clarke CA, Glaser SL. Cancer survival in US racial/ethnic groups: heterogeneity among Asian ethnic subgroups. Arch Intern Med. 2003;163:631.
7. Parikh-Patel A, Mills PK, Jain RV. Breast cancer survival among South Asian women in California (United States). Cancer Causes Control. 2006;17:267-272.
8. U.S. Census Bureau. State and County QuickFacts: California. Available at URL: http://quickfacts.census.gov/qfd/states/06000.html Accessed July 19, 2006.
9. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12:703-711.
10. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. Chichester, UK: John Wiley & Sons; 1995.
11. Penson DF, Albertsen PC, Nelson PS, et al. Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst. 2001;93:1822-1823.
12. Ross RK, Bernstein L, Lobo RA, et al. 5-alpha-Reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 1992;339:887-889.
13. Lookingbill PD, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ. Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab. 1991;72:1242-1248.
14. de Jong FH, Oishi K, Hayes RB, et al. Peripheral hormone levels in controls and patients with prostate cancer or benign prostatic hyperplasia: results from the Dutch-Japanese Case-Control Study. Cancer Res. 1991;51:3445-3450.
15. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med. 1993;118:793-803.
16. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst. 1994;86:281-286.
17. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in nude fed a low-fat diet. J Natl Cancer Inst. 1995;87:1456-1462.
18. Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men. Int J Cancer. 1997;73:634-638.
19. Kolonel LN, Nomura AM, Cooney RV. Dietary fat and prostate cancer: current status. J Natl Cancer Inst. 1999;91:414-428.
20. Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control. 1996;7:83-94.
21. Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr. 2001;74:549-554.
22. Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami HO, Wolk A. Dairy products, calcium, phosphorus, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control. 1998;9:559-566.
23. Wilkinson S, Chodak GW. Critical review of complementary therapies for prostate cancer. J Clin Oncol. 2003;21:2199-2210.
24. Giovannucci E, Rimm EB, Colditz GA, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst. 1993;85:1571-1579.
25. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst. 2000;92:61-68.
26. Jian L, Du CJ, Lee AH, Binns CW. Do dietary lycopene and other carotenoids protect against prostate cancer? Int J Cancer. 2005;113:1010-1014.
27. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer. 1994;21:113-131.
28. Kolonel LN, Hankin JH, Whittemore AS, et al. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev. 2000;9:795-804.
29. Strom SS, Yamamura Y, Duphorne CM, et al. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer. 1999;33:20-25.
30. Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control. 1998;9:553-557.
31. Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 2003;12:665-668.
32. Yan L, Spitznagel EL. Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer. 2005;117:667-669.
33. Rodriguez C, Freedland SJ, Deka A, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2007;16:63-69.
34. Wright ME, Chang SC, Schatzkin A, et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer. 2007;109:675-684.
35. 2005 California Health Interview Survey. Available at URL: http://www.chis.ucla.edu/ Accessed January 24, 2007.
36. Jain RV, Mills PK, Parikh-Patel A. Cancer incidence in the south Asian population of California, 1988-2000. J Carcinog. 2005;4:21-33.
37. Liu WL, Kasl S, Flannery JT, Lindo A, Dubrow R. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Control. 1995;6:425-430.